{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:19:00Z","timestamp":1790864340966,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1992,8,1]],"date-time":"1992-08-01T00:00:00Z","timestamp":712627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1992,8]]},"DOI":"10.1007\/bf02245114","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T17:38:33Z","timestamp":1131989913000},"page":"289-294","source":"Crossref","is-referenced-by-count":33,"title":["Effects of buspirone and gepirone on IV cocaine self-administration in rhesus monkeys"],"prefix":"10.1007","volume":"108","author":[{"given":"Lisa H.","family":"Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Balster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02245114_CR1","first-page":"3","volume":"2","author":"NA Ator","year":"1991","unstructured":"Ator NA (1991) Discriminative stimulus effects of the novel anxiolytic buspirone. Behav Pharmacol 2:3\u201314","journal-title":"Behav Pharmacol"},{"key":"BF02245114_CR2","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1097\/00004714-199006001-00007","volume":"10","author":"RL Balster","year":"1990","unstructured":"Balster RL (1990) Abuse potential of buspirone and related drugs. J Clin Psychopharmacol 10:31S-37S","journal-title":"J Clin Psychopharmacol"},{"issue":"suppl 1","key":"BF02245114_CR3","first-page":"49","volume":"22","author":"F Bueno","year":"1989","unstructured":"Bueno F (1989) Buspirone in the treatment of alcoholic patients. Psychopathology 22[suppl 1]:49\u201359","journal-title":"Psychopathology"},{"key":"BF02245114_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0741-8329(87)90060-7","volume":"4","author":"DM Collins","year":"1987","unstructured":"Collins DM, Myers RD (1987) Buspirone attenuates volitional alcohol intake in the chronically drinking monkey. Alcohol 4:49\u201356","journal-title":"Alcohol"},{"key":"BF02245114_CR5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00405254","volume":"16","author":"G Deneau","year":"1969","unstructured":"Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacologia 16:30\u201343","journal-title":"Psychopharmacologia"},{"key":"BF02245114_CR6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1358\/dof.1985.010.06.67201","volume":"10","author":"MS Eison","year":"1985","unstructured":"Eison MS, Yevich JP, Farney RF (1985) Gepirone hydrochloride. Drugs of the Future 10:456\u2013457","journal-title":"Drugs of the Future"},{"key":"BF02245114_CR7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(86)90577-0","volume":"24","author":"AS Eison","year":"1986","unstructured":"Eison AS, Eison MS, Stanley M, Riblet LA (1986) Serotonergic mechanisms of buspirone and gepirone. Pharmacol Biochem Behav 24:701\u2013707","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245114_CR8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archpsyc.1989.01810030094013","volume":"46","author":"F Gawin","year":"1989","unstructured":"Gawin F, Compton M, Byck R (1989) Buspirone reduces smoking. Arch Gen Psychiatry 46:288\u2013289","journal-title":"Arch Gen Psychiatry"},{"key":"BF02245114_CR9","first-page":"43","volume":"30","author":"CE Johanson","year":"1978","unstructured":"Johanson CE, Balster RL (1978) A summary of the results of a drug self-administration study using substitution procedures in rhesus monkey. Bull Narc 30:43\u201354","journal-title":"Bull Narc"},{"key":"BF02245114_CR10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0091-3057(90)90214-3","volume":"35","author":"JB Kamien","year":"1990","unstructured":"Kamien JB, Woolverton WL (1990) Buspirone blocks the discriminative stimulus effects of apomorphine in monkeys. Pharmacol Biochem Behav 35:117\u2013120","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245114_CR11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0091-3057(88)90192-X","volume":"29","author":"JI Koenig","year":"1988","unstructured":"Koenig JI, Meltzer HY, Gudelsky GA (1988) 5-Hydroxytryptamine 1A receptor-mediated effects of buspirone, gepirone and ipsapirone. Pharmacol Biochem Behav 29:711\u2013715","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245114_CR12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF01248997","volume":"57","author":"BA McMillan","year":"1983","unstructured":"McMillan BA, Mattiace LA (1983) Comparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug. J Neural Transm 57:255\u2013265","journal-title":"J Neural Transm"},{"key":"BF02245114_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ddr.430200103","volume":"20","author":"MA Nader","year":"1990","unstructured":"Nader MA, Barrett JE (1990) Effects of chlordiazepoxide, buspirone, and serotonin receptor agonists and antagonists on responses of squirrel monkeys maintained under second-order schedules of intramuscular cocaine injection or food presentation. Drug Dev Res 20:5\u201317","journal-title":"Drug Dev Res"},{"key":"BF02245114_CR14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/med.2610100302","volume":"10","author":"JS New","year":"1990","unstructured":"New JS (1990) The discovery and development of buspirone: a new approach to the treatment of anxiety. Med Res Rev 10:283\u2013326","journal-title":"Med Res Rev"},{"key":"BF02245114_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0741-8329(88)90012-2","volume":"5","author":"TU Privette","year":"1988","unstructured":"Privette TU, Hornsby RL, Myers RD (1988) Buspirone alters alcohol drinking induced in rats by tetrahydropapaveroline injected into brain monoaminergic pathways. Alcohol 5:147\u2013152","journal-title":"Alcohol"},{"key":"BF02245114_CR16","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1096\/fasebj.2.9.2836252","volume":"2","author":"DP Taylor","year":"1988","unstructured":"Taylor DP (1988) Buspirone, a new approach to the treatment of anxiety. FASEB J 2:2445\u20132452","journal-title":"FASEB J"},{"key":"BF02245114_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00422098","volume":"26","author":"MC Wilson","year":"1972","unstructured":"Wilson MC, Schuster CR (1972) The effects of chlorpromazine on psychomotor stimulant self-administration in the rhesus monkey. Psychopharmacologia 26:115\u2013126","journal-title":"Psychopharmacologia"},{"key":"BF02245114_CR18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00421274","volume":"31","author":"MC Wilson","year":"1973","unstructured":"Wilson MC, Schuster CR (1973) The effects of stimulants and depressants on cocaine self-administration behavior in the rhesus monkey. Psychopharmacologia 31:291\u2013304","journal-title":"Psychopharmacologia"},{"key":"BF02245114_CR19","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0091-3057(86)90553-8","volume":"24","author":"WL Woolverton","year":"1986","unstructured":"Woolverton WL (1986) Effects of a D1 and D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem Behav 24:531\u2013535","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02245114_CR20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/jm00356a014","volume":"28","author":"JP Yevich","year":"1983","unstructured":"Yevich JP, Temple DL Jr., New JS, Taylor DP, Riblet LA (1983) Buspirone analogues. 1. Structure-activity relationships of a series ofN-aryl-and heteroarylpiperazine derivatives. J Med Chem 28:194\u2013203","journal-title":"J Med Chem"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02245114\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02245114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T13:33:14Z","timestamp":1557927194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02245114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,8]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1992,8]]}},"alternative-id":["BF02245114"],"URL":"https:\/\/doi.org\/10.1007\/bf02245114","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,8]]}}}